01When the next course waits for ovaries to shrink
If the ovary enlarges, more clomiphene is withheld until ovaries return to pretreatment size. The next course should use a lower dose or a shorter run.
Cystic enlargement usually recedes in days to weeks after stopping. Manage conservatively unless there is a surgical indication. Fragile large ovaries make rough pelvic exams a bad idea.
02How fast the syndrome can move
Progression can sit inside a day or stretch over several days. Some cases followed cyclic clomiphene or clomiphene plus gonadotropins. If conception occurs, a rapid slide into the severe form can follow.
Maximal ovarian size may not arrive until several days after the last recommended 50 mg. Feeling better on the last tablet morning does not close the watch.
03What to do when pain arrives with new spots
Visual change plus OHSS-type pain is two problems in one evening. Stop the tablet. Do not drive into glare. The vision-flag pulse holds the eye stop.
Transient liver-test abnormalities have been reported with OHSS. That does not reopen clomiphene in someone who already has liver disease. See liver.
04Why PCOS starts on the shortest 50 mg course
Some polycystic ovary patients are unusually sensitive to gonadotropin and can over-respond to usual doses. The first course uses the lowest recommended dose and the shortest duration.
That is the 50 mg five-day start unless a clinician writes even lower. The 50 mg lock is the tablet. This page is the over-response.
05What early warning signs show up first
Pain, distention, nausea, vomiting, diarrhea, and weight gain are the early list. Electrolyte shifts, hypovolemia, hemoconcentration, and low protein can follow.
Death has occurred from hypovolemic shock, hemoconcentration, or thromboembolism. That sentence is why a 'wait and see if I am just bloated' clinic delay is expensive.
06How OHSS differs from ordinary enlargement
Ovarian enlargement at 13.6% was the most common trial event. OHSS is called out as a separate medical event. Severe pictures include gross ovarian enlargement, ascites, dyspnea, oliguria, and pleural effusion.
Further listed complications include pericardial effusion, anasarca, hydrothorax, acute abdomen, hypotension, renal failure, pulmonary edema, internal hemorrhage, clots, ovarian torsion, and ARDS.